APA (7th ed.) Citation

D, Y., NC, D., Z, W., MD, O., JA, S., S, G., . . . W, Q. (2026). Safety and preliminary efficacy of allogeneic bone marrow-derived mesenchymal stromal cells (BMSC) for painful lumbar facet arthropathy: Study protocol for a randomised, double-blinded, placebo-controlled, crossover phase II clinical trial. BMJ open, 16(7), e113509. https://doi.org/10.1136/bmjopen-2025-113509

Chicago Style (17th ed.) Citation

D, Yan, et al. "Safety and Preliminary Efficacy of Allogeneic Bone Marrow-derived Mesenchymal Stromal Cells (BMSC) for Painful Lumbar Facet Arthropathy: Study Protocol for a Randomised, Double-blinded, Placebo-controlled, Crossover Phase II Clinical Trial." BMJ Open 16, no. 7 (2026): e113509. https://doi.org/10.1136/bmjopen-2025-113509.

MLA (9th ed.) Citation

D, Yan, et al. "Safety and Preliminary Efficacy of Allogeneic Bone Marrow-derived Mesenchymal Stromal Cells (BMSC) for Painful Lumbar Facet Arthropathy: Study Protocol for a Randomised, Double-blinded, Placebo-controlled, Crossover Phase II Clinical Trial." BMJ Open, vol. 16, no. 7, 2026, p. e113509, https://doi.org/10.1136/bmjopen-2025-113509.